Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:	Lariam Mefloquine hydrochloride 274.09mg equivalent to mefloquine 250mg Tablet Roche Products (NZ) Limited F. Hoffmann-La Roche Limited, Basel, Switzerland Cenexi SAS, Fontenay-sous-Bois, France
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Myprax Venlafaxine hydrochloride 42.5mg equivalent to venlafaxine 37.5mg Modified release capsule REX Medical Limited Cipla Limited, Daund, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Myprax Venlafaxine hydrochloride 85mg equivalent to venlafaxine 75mg Modified release capsule REX Medical Limited Cipla Limited, Daund, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Myprax Venlafaxine hydrochloride 170mg equivalent to venlafaxine 150mg Modified release capsule REX Medical Limited Cipla Limited, Daund, India

Dated this 12th day of January 2017.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Issue Number